Real-world experience supporting the role of oncologic resection and adjuvant chemotherapy in biliary tract cancers.

In the total cohort, the median OS was 29.4 versus 25.9 months with and without adjuvant therapy (HR: 0.79, 95% CI: 0.61–1.02), although this did not reach statistical significance ( Figure 4 ).

also in 111,027 other papers